Canadian Companies with Highest Profit Margins — Health Care
Net profit margin ranking for TSX and TSXV companies.
Updated November 11, 2026179 companiesTotal market cap $1746.6B
Showing 179 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | Revenue (TTM) | Profit Margin |
|---|---|---|---|---|---|
| 1 | Daxor Corporation | DXR:US | $49M | $31,360 | 19861.41% |
| 2 | Rallybio Corp | RLYB:US | $85M | $434,000 | 6177.42% |
| 3 | Advanced Biomed Inc. Common Stock | ADVB:US | $3M | $127,637 | 5231.30% |
| 4 | Kyntra Bio, Inc. | KYNB:US | $15M | $5M | 3968.63% |
| 5 | Hyperion DeFi, Inc. | HYPD:US | $38M | $1M | 474.87% |
| 6 | Elutia Inc. | ELUT:US | $37M | $14M | 400.17% |
| 7 | Omeros Corporation | OMER:US | $1.3B | $38M | 324.88% |
| 8 | AnaptysBio Inc | ANAB:US | $1.4B | $106M | 246.96% |
| 9 | Fortress Biotech Inc Pref Series A | FBIOP:US | $78M | $68M | 163.32% |
| 10 | Fortress Biotech Inc | FBIO:US | $62M | $68M | 163.32% |
| 11 | Standard Biotools Inc | LAB:US | $251M | $84M | 157.62% |
| 12 | Rigel Pharmaceuticals Inc | RIGL:US | $792M | $288M | 106.59% |
| 13 | Aurinia Pharmaceuticals Inc | AUPH:US | $2.2B | $322M | 97.68% |
| 14 | Arbutus Biopharma Corp | ABUS:US | $560M | $182M | 84.23% |
| 15 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $179M | $9M | 74.06% |
| 16 | Ascendis Pharma AS | ASND:US | $16.9B | $1.0B | 70.85% |
| 17 | Protagonist Therapeutics Inc | PTGX:US | $8.6B | $552M | 62.04% |
| 18 | Lakefront Biotherapeutics NV | LKFT:US | $2.2B | $991M | 60.23% |
| 19 | Q32 Bio Inc | QTTB:US | $279M | $54M | 60.02% |
| 20 | Cipher Pharmaceuticals Inc | CPH:TO | $343M | $50M | 58.42% |
| 21 | LENSAR Inc | LNSR:US | $67M | $60M | 57.57% |
| 22 | TG Therapeutics Inc | TGTX:US | $9.2B | $800M | 55.22% |
| 23 | BioLife Solutions Inc | BLFS:US | $1.9B | $107M | 54.35% |
| 24 | Alnylam Pharmaceuticals Inc | ALNY:US | $20.9B | $5.0B | 52.85% |
| 25 | Zevra Therapeutics Inc. | ZVRA:US | $722M | $148M | 52.80% |
| 26 | Theravance Biopharma Inc | TBPH:US | $884M | $104M | 51.58% |
| 27 | Krystal Biotech Inc | KRYS:US | $8.9B | $470M | 47.91% |
| 28 | Compugen | CGEN:US | $186M | $74M | 47.56% |
| 29 | Innoviva Inc | INVA:US | $1.4B | $438M | 44.13% |
| 30 | Nurix Therapeutics Inc | NRIX:US | $1.8B | $702M | 42.01% |
| 31 | CorMedix Inc | CRMD:US | $415M | $462M | 40.49% |
| 32 | United Therapeutics Corporation | UTHR:US | $24.8B | $3.2B | 38.61% |
| 33 | Ironwood Pharmaceuticals Inc | IRWD:US | $727M | $400M | 37.38% |
| 34 | Exelixis Inc | EXEL:US | $17.5B | $2.5B | 35.45% |
| 35 | Eton Pharmaceuticals Inc | ETON:US | $1.9B | $141M | 35.35% |
| 36 | ADMA Biologics Inc | ADMA:US | $2.8B | $519M | 35.14% |
| 37 | SANUWAVE Health, Inc. Common Stock | SNWV:US | $19M | $44M | 34.66% |
| 38 | Indivior PLC Ordinary Shares | INDV:US | $4.3B | $1.4B | 32.75% |
| 39 | Supernus Pharmaceuticals, Inc. | SUPN:US | $1.6B | $1.4B | 32.75% |
| 40 | argenx NV ADR | ARGX:US | $58.3B | $5.9B | 31.73% |
| 41 | Agenus Inc | AGEN:US | $324M | $134M | 30.77% |
| 42 | Liquidia Technologies Inc | LQDA:US | $4.3B | $451M | 30.74% |
| 43 | Vertex Pharmaceuticals Inc | VRTX:US | $138.7B | $13.0B | 30.70% |
| 44 | Utah Medical Products Inc | UTMD:US | $207M | $35M | 30.48% |
| 45 | ACADIA Pharmaceuticals Inc | ACAD:US | $3.7B | $1.2B | 30.13% |
| 46 | DRI Healthcare Trust | DHT-U:TO | $744M | $204M | 29.59% |
| 47 | DRI Healthcare Trust | DHT-UN:TO | $1.1B | $204M | 29.59% |
| 48 | Regeneron Pharmaceuticals Inc | REGN:US | $93.6B | $16.9B | 28.51% |
| 49 | Cronos Group Inc | CRON:US | $1.3B | $206M | 28.04% |
| 50 | Cronos Group Inc | CRON:TO | $1.8B | $206M | 28.04% |
| 51 | OrganiGram Holdings Inc | OGI:TO | $175M | $309M | 28.02% |
| 52 | OrganiGram Holdings Inc | OGI:US | $126M | $309M | 28.02% |
| 53 | SBC Medical Group Holdings Incorporated | SBC:US | $541M | $175M | 27.99% |
| 54 | Halozyme Therapeutics Inc | HALO:US | $11.7B | $1.8B | 26.93% |
| 55 | Iradimed Co | IRMD:US | $1.1B | $89M | 26.85% |
| 56 | CareDx Inc | CDNA:US | $4.1B | $497M | 25.86% |
| 57 | Royalty Pharma Plc | RPRX:US | $39.5B | $2.6B | 25.70% |
| 58 | Intuitive Surgical Inc | ISRG:US | $159.7B | $11.6B | 25.54% |
| 59 | IDEXX Laboratories Inc | IDXX:US | $55.7B | $4.7B | 25.36% |
| 60 | YD Bio Ltd | YDES:US | $475M | $1M | 24.67% |
| 61 | NewGenIvf Group Limited Class A Ordinary Shares | NIVF:US | $4M | $5M | 24.16% |
| 62 | Amgen Inc | AMGN:US | $249.0B | $38.9B | 24.14% |
| 63 | Alector Inc | ALEC:US | $366M | $173M | 23.87% |
| 64 | LeMaitre Vascular Inc | LMAT:US | $1.9B | $269M | 23.51% |
| 65 | Veracyte Inc | VCYT:US | $2.1B | $582M | 21.80% |
| 66 | MBody AI Ltd. | MBAI:US | $37M | $2M | 21.75% |
| 67 | Sinovac Biotech Ltd | SVA:US | $642M | $511M | 21.61% |
| 68 | InMode Ltd | INMD:US | $777M | $375M | 20.69% |
| 69 | Nutex Health Inc | NUTX:US | $1.2B | $797M | 20.68% |
| 70 | Ligand Pharmaceuticals Incorporated | LGND:US | $6.3B | $254M | 20.27% |
| 71 | MeiraGTx Holdings PLC | MGTX:US | $911M | $398M | 19.87% |
| 72 | TransMedics Group Inc | TMDX:US | $3.3B | $728M | 19.85% |
| 73 | Illumina Inc | ILMN:US | $33.4B | $4.5B | 19.72% |
| 74 | Auxly Cannabis Group Inc | XLY:TO | $360M | $166M | 19.69% |
| 75 | Agilent Technologies Inc | A:US | $43.3B | $7.4B | 19.53% |
| 76 | DexCom Inc | DXCM:US | $30.2B | $5.1B | 19.42% |
| 77 | Neurocrine Biosciences Inc | NBIX:US | $17.1B | $3.7B | 18.98% |
| 78 | Medpace Holdings Inc | MEDP:US | $18.3B | $2.8B | 18.24% |
| 79 | Harmony Biosciences Holdings | HRMY:US | $2.0B | $989M | 18.05% |
| 80 | Biosyent Inc. | RX:V | $199M | $56M | 17.73% |
| 81 | HealthEquity Inc | HQY:US | $8.6B | $1.4B | 17.36% |
| 82 | Lantheus Holdings Inc | LNTH:US | $6.6B | $1.6B | 17.28% |
| 83 | Genmab AS | GMAB:US | $34.3B | $4.3B | 16.97% |
| 84 | Corcept Therapeutics Incorporated | CORT:US | $8.2B | $964M | 16.84% |
| 85 | Spero Therapeutics Inc | SPRO:US | $60M | $47M | 15.71% |
| 86 | Brainsway Ltd | BWAY:US | $449M | $61M | 15.56% |
| 87 | Precigen Inc | PGEN:US | $1.7B | $157M | 15.55% |
| 88 | Pro-Dex Inc | PDEX:US | $202M | $80M | 15.12% |
| 89 | Medical Facilities Corporation | DR:TO | $250M | $265M | 14.57% |
| 90 | Sotera Health Co | SHC:US | $4.6B | $1.2B | 14.11% |
| 91 | Bio-Techne Corp | TECH:US | $11.4B | $1.2B | 14.00% |
| 92 | BeOne Medicines AG | ONC:US | $47.7B | $6.6B | 13.86% |
| 93 | NexgenRX Inc. | NXG:V | $47M | $19M | 13.60% |
| 94 | The Cooper Companies, Inc | COO:US | $11.9B | $4.2B | 13.46% |
| 95 | Insulet Corporation | PODD:US | $10.4B | $3.2B | 13.44% |
| 96 | Amphastar P | AMPH:US | $1.2B | $746M | 13.27% |
| 97 | LivaNova PLC | LIVN:US | $5.0B | $1.5B | 13.01% |
| 98 | Covalon Technologies Ltd. | COV:V | $119M | $34M | 12.78% |
| 99 | CorVel Corp | CRVL:US | $4.1B | $1.0B | 12.02% |
| 100 | Align Technology Inc | ALGN:US | $11.7B | $4.2B | 11.83% |
| 101 | UFP Technologies Inc | UFPT:US | $2.5B | $650M | 11.78% |
| 102 | Kamada | KMDA:US | $445M | $192M | 11.60% |
| 103 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $7.8B | $946M | 11.58% |
| 104 | ANI Pharmaceuticals Inc | ANIP:US | $1.5B | $1.0B | 11.22% |
| 105 | Waystar Holding Corp. Common Stock | WAY:US | $5.6B | $1.3B | 10.70% |
| 106 | Aveanna Healthcare Holdings Inc | AVAH:US | $2.9B | $2.6B | 10.56% |
| 107 | Cannara Biotech Inc | LOVE:V | $181M | $112M | 10.52% |
| 108 | Puma Biotechnology Inc | PBYI:US | $433M | $232M | 10.27% |
| 109 | Vericel Corp Ord | VCEL:US | $2.8B | $324M | 10.27% |
| 110 | GE HealthCare Technologies Inc. | GEHC:US | $38.0B | $21.6B | 9.95% |
| 111 | Merit Medical Systems Inc | MMSI:US | $5.2B | $1.6B | 9.94% |
| 112 | Simulations Plus Inc | SLP:US | $374M | $82M | 9.88% |
| 113 | Bioventus Inc | BVS:US | $727M | $586M | 9.78% |
| 114 | Caris Life Sciences, Inc. Common Stock | CAI:US | $7.3B | $1.0B | 9.17% |
| 115 | Embecta Corp | EMBC:US | $351M | $1.0B | 8.59% |
| 116 | Hydreight Technologies Inc | NURS:V | $167M | $78M | 8.59% |
| 117 | Niagen Bioscience, Inc. | NAGE:US | $181M | $122M | 8.37% |
| 118 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $5.5B | $397M | 8.35% |
| 119 | Sanofi ADR | SNY:US | $112.7B | $51.0B | 8.19% |
| 120 | Addus HomeCare Corporation | ADUS:US | $2.3B | $1.5B | 7.39% |
| 121 | CareCloud, Inc. | CCLD:US | $107M | $131M | 7.36% |
| 122 | Sucro Limited | SUGR:V | $216M | $561M | 7.16% |
| 123 | CareRx Corp | CRRX:TO | $197M | $377M | 7.13% |
| 124 | The Ensign Group Inc | ENSG:US | $10.6B | $5.7B | 7.03% |
| 125 | Progyny Inc | PGNY:US | $2.6B | $1.3B | 6.80% |
| 126 | Incyte Corporation | INCY:US | $24.8B | $6.0B | 6.71% |
| 127 | Tactile Systems Technology Inc | TCMD:US | $583M | $356M | 6.68% |
| 128 | Phibro Animal Health Corporation | PAHC:US | $1.4B | $1.5B | 6.67% |
| 129 | Grifols SA ADR | GRFS:US | $5.7B | $7.6B | 6.44% |
| 130 | Pharming Group NV | PHAR:US | $870M | $387M | 6.25% |
| 131 | HealthStream Inc | HSTM:US | $884M | $328M | 6.25% |
| 132 | Extendicare Inc | EXE:TO | $2.6B | $2.2B | 6.06% |
| 133 | JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares | ZJYL:US | $629M | $20M | 5.95% |
| 134 | Vitalhub Corp | VHI:TO | $495M | $127M | 5.89% |
| 135 | Arcutis Biotherapeutics Inc | ARQT:US | $3.2B | $509M | 5.88% |
| 136 | ICON PLC | ICLR:US | $15.3B | $8.2B | 5.26% |
| 137 | Pacira BioSciences, Inc. | PCRX:US | $1.5B | $743M | 5.08% |
| 138 | Viemed Healthcare Inc | VMD:US | $339M | $310M | 5.03% |
| 139 | Sienna Senior Living Inc | SIA:TO | $2.3B | $1.1B | 4.82% |
| 140 | The Joint Corp | JYNT:US | $94M | $59M | 4.81% |
| 141 | Collegium Pharmaceutical Inc | COLL:US | $752M | $815M | 4.68% |
| 142 | OPTIMIZERx Corp | OPRX:US | $178M | $99M | 4.66% |
| 143 | NRC Health | NRC:US | $566M | $144M | 4.48% |
| 144 | Jazz Pharmaceuticals PLC | JAZZ:US | $15.1B | $4.7B | 4.36% |
| 145 | Lifestance Health Group Inc | LFST:US | $5.2B | $1.7B | 4.29% |
| 146 | Omada Health, Inc. Common Stock | OMDA:US | $936M | $333M | 4.21% |
| 147 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX:US | $7.4B | $3.2B | 4.17% |
| 148 | Nova Leap Health Corp | NLH:V | $39M | $34M | 4.01% |
| 149 | Telix Pharmaceuticals Limited | TLX:US | $3.3B | $891M | 3.76% |
| 150 | Option Care Health Inc | OPCH:US | $4.7B | $5.8B | 3.74% |
| 151 | Omnicell Inc | OMCL:US | $1.7B | $1.2B | 3.59% |
| 152 | Biogen Inc | BIIB:US | $37.7B | $10.3B | 3.38% |
| 153 | HUTCHMED DRC | HCM:US | $2.6B | $549M | 3.26% |
| 154 | biote Corp | BTMD:US | $36M | $184M | 3.19% |
| 155 | Henry Schein Inc | HSIC:US | $9.5B | $13.7B | 3.07% |
| 156 | Pennant Group Inc | PNTG:US | $1.3B | $1.2B | 3.05% |
| 157 | Kewaunee Scientific Corporation | KEQU:US | $98M | $277M | 2.97% |
| 158 | ICU Medical Inc | ICUI:US | $4.3B | $2.2B | 2.76% |
| 159 | BrightSpring Health Services, Inc. Common Stock | BTSG:US | $13.8B | $15.3B | 2.69% |
| 160 | ImmuCell Corporation | ICCC:US | $93M | $31M | 2.57% |
| 161 | Varex Imaging Corp | VREX:US | $783M | $865M | 2.56% |
| 162 | AtriCure Inc | ATRC:US | $2.9B | $590M | 2.52% |
| 163 | Goodrx Holdings Inc | GDRX:US | $1.2B | $785M | 2.07% |
| 164 | Mesa Laboratories Inc | MLAB:US | $718M | $250M | 1.92% |
| 165 | Medline Inc. Class A Common Stock | MDLN:US | $53.6B | $30.7B | 1.85% |
| 166 | NeuPath Health Inc | NPTH:V | $32M | $89M | 1.51% |
| 167 | Privia Health Group Inc | PRVA:US | $3.1B | $2.4B | 1.43% |
| 168 | Astrana Health Inc | ASTH:US | $1.7B | $3.9B | 1.36% |
| 169 | rYojbaba Co., Ltd. Common Shares | RYOJ:US | $29M | $9M | 1.28% |
| 170 | InnovAge Holding Corp | INNV:US | $1.3B | $1.0B | 0.88% |
| 171 | Integra LifeSciences Holdings | IART:US | $1.0B | $1.7B | 0.79% |
| 172 | Alignment Healthcare LLC | ALHC:US | $1.5B | $4.9B | 0.59% |
| 173 | Delcath Systems Inc | DCTH:US | $518M | $95M | 0.56% |
| 174 | Medirom Healthcare Technologies Inc | MRM:US | $2M | $8.1B | 0.50% |
| 175 | Clover Health Investments Corp | CLOV:US | $2.6B | $2.7B | 0.45% |
| 176 | WELL Health Technologies Corp | WELL:TO | $1.1B | $1.5B | 0.25% |
| 177 | STAAR Surgical Company | STAA:US | $1.3B | $328M | 0.16% |
| 178 | LifeMD Inc Preferred Series A | LFMDP:US | - | $192M | 0.11% |
| 179 | LifeMD Inc | LFMD:US | $114M | $192M | 0.11% |
Frequently Asked Questions
Which Canadian company ranks #1 by profit margin in Health Care?
As of November 11, 2026, Daxor Corporation (DXR:US) ranks #1 in Health Care at 19861.41%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of November 11, 2026.
How many companies are in this profit margin list?
This view shows 179 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Revenue Growth
Companies with strongest year-over-year revenue growth
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth